Karakteristik Tumor Trofoblas Gestasional Risiko Tinggi di RSUP Dr. Hasan Sadikin Bandung Tahun 2019 – 2021

Yudi Mulyana Hidayat, Salsa Bila Megantari, Ali Budi Harsono, Dodi Suardi, Kemala Isnainiasih Mantilidewi


Abstract


Tujuan: Penelitian ini bertujuan mengidentifikasi karakteristik demografi dan klinis pasien TTG risiko tinggi di RSUP Dr. Hasan Sadikin Bandung pada tahun 2019 – 2021.
Metode: Penelitian ini menggunakan analisis secara deskriptif yang didapatkan melalui rekam medis pasien TTG risiko tinggi di RSUP Dr. Hasan Sadikin Bandung pada tahun 2019 – 2021 dengan metode total sampling.
Hasil: Terdapat 69 rekam medis pasien yang memenuhi kriteria inklusi dan eksklusi. Hasil tersebut menunjukkan banyaknya pasien yang memiliki pendidikan terakhir pada jenjang SMA (49%), tidak memiliki pekerjaan (84%) yang didominasi oleh ibu rumah tangga, beretnis Sunda (93%), berasal dari daerah wilayah IV Priangan (54%), berusia lebih dari 40 tahun (57%), multipara (61%), memiliki riwayat mola (71%), interval dengan kehamilan sebelumnya 7 hingga 12 bulan (54%), kadar β-hCG yang diukur sebelum terapi sebanyak 10.000 - <100.000 mIU/mL (42%), tidak terjadi metastasis (68%)  diikuti hasil terjadinya metastasis pada paru-paru (26%), tidak memiliki hasil pemeriksaan tipe histopatologi (61%) diikuti hasil tipe histopatologi koriokarsinoma (33%), dan memiliki stadium I  (59%).
Kesimpulan: Kasus TTG risiko tinggi di RSUP Dr. Hasan Sadikin Bandung pada tahun 2019 – 2021 lebih umum terjadi pada pasien yang memiliki pendidikan terakhir pada jenjang SMA, tidak memiliki pekerjaan yang didominasi oleh ibu rumah tangga, beretnis Sunda, berasal dari daerah wilayah IV Priangan, berusia lebih dari 40 tahun, riwayat multipara, riwayat mola, interval dengan kehamilan sebelumnya 7 hingga 12 bulan, kadar β-hCG yang diukur sebelum terapi sebanyak 10.000 - < 100.000 mIU/mL, tidak terjadi metastasis, dan memiliki stadium I.

Characteristics of High Risk Gestational Trophoblast Neoplasia at Dr. Hasan Sadikin General Hospital Bandung in 2019 – 2021

Abstract
Objective: This research aims to identify the demographic and clinical characteristics of patients with high-risk GTN at Dr. Hasan Sadikin Bandung in 2019–2021.
Method: This research used descriptive analysis, which was obtained from the medical records of patients with high-risk GTN at Dr. Hasan Sadikin General Hospital Bandung in 2019–2021 using the total sampling method.
Results: 69 patient medical records met the inclusion and exclusion criteria. These results show that the number of patients who have had their last education at the high school level (49%), do not have a job (84%), are dominated by housewives, are of Sundanese ethnicity (93%), and come from region IV Priangan (54%), aged over 40 years (57%), multiparous (61%), had a history of molar (71%), an interval with a previous pregnancy of 7 to 12 months (54%), β-hCG level measured before therapy of 10,000– 100,000 mIU/mL (42%), no metastases (68%) followed by lung metastases (26%), no histopathological type (61%) followed by choriocarcinoma histopathological type (33%), and staging I (59%).
Conclusion: High-risk GTN cases at Dr. Hasan Sadikin Bandung in 2019 – 2021 are more common in patients who have the last education at the high school level, do not have a job dominated by housewives, are of Sundanese ethnicity, come from the IV Priangan region, are over 40 years old, have a history of multiparas, a history of moles, an interval with a previous pregnancy of 7 to 12 months, β-hCG level measured before therapy was 10,000– 100,000 mIU/mL, no metastases occurred, and had stage I.

Key words: Characteristics, Demographic, Gestational Trophoblastic Neoplasia, High Risk


Keywords


Karakteristik; Demografi; Tumor Trofoblas Gestasional; Risiko Tinggi

Full Text:

PDF

References


Randriamaroson N, Razakanaivo M, Andrianandrasana NO, Solofonirina ZA, Rafaramino F. Gestational trophoblastic neoplasia: clinical and therapeutic profile in Madagascar. Open J Obstet Gynecol. 2020;10:946– 56.

Himpunan Onkologi Ginekologi Indonesia. Pedoman Pelayanan Medik Kanker Ginekologi Edisi ke 2. 2010;77–93.

Braga A, Mora P, Melo AC de, Nogueira-Rodrigues A, Amim-Junior J, Rezende-Filho J, et al. Challenges in the diagnosis and treatment of gestational trophoblastic neoplasia worldwide. World J Clin Oncol. 2019;10(2):28–37.

Bruce S, Sorosky J. Gestational Trophoblastic Disease [Internet]. StatPearls. StatPearls Publishing; 2020 [cited 2021 Jan 21]. 1–2 p. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29261918

Sinaga, R. J., Tobing, M. D. L. & Harsono, A. B. Characteristic of low risk gestational thropoblastic neoplasia patient with chemoresistance to methotrexate at hasan sadikin hospital bandung in 2011-2015. J.Obgynia.

Raudina F, Hidayat YM, Rachmayati S. Response to Chemotherapy in Patients with Gestational Trophoblastic Neoplasia in Dr. Hasan Sadikin General Hospital. AMJ. 2020;7(3):128-35.

Ghosh J, Agarwal P, Kapoor A, Philip DSJ, Choudhary V, Bajpai J, et al. Clinical, socioeconomic characteristics, treatment and reproductive outcomes of patients with gestasional trophoblastic neoplasia at a tertiary care hospital in India. Gynecol Oncol 159, 347–348 (2020).

Ferraz L, Ramos CAB, Braga A, Velarde LGC, Elias KM, Horowitz NS, et al. Association between antioxidant vitamins and oxidative stress among patients with a complete hydatidiform mole. Clinics. 2020;75(e1724):1–6.

Al Riyami N, Al Riyami M, Al Hajri AT, Al Saidi S, Salman B, Al Kalbani M. Gestational trophoblastic disease at Sultan Qaboos University Hospital: Prevalence, risk factors, histological features, sonographic findings, and outcomes. Oman Med J. 2019;34(3):200–4.

Alifrangis C, et al. EMA/CO for high-risk gestational trophoblastic neoplasia: Good outcomes with induction low-dose etoposide-cisplatin and genetic analysis. Journal of Clinical Oncology 31, 280–286 (2013).

American Cancer Society. Gestational Trophoblastic Disease Causes, Risk Factors, and Prevention. 2017;1–5. Available from: www.cancer.org/cancer/gestational-trophoblastic-disease/references.html

Khalkinst J, Fasihah IS, Kusmala YY. Karakteristik Penderita Penyakit Trofoblas Gestasional di Rumah Sakit Hasan Sadikin Bandung Tahun 2013-2015. 2010;8719(2006).

Bishop BN, Edemekong PF. Choriocarcinoma. [Updated 2022 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-.

Kong Y, et al. Clinical characteristics and prognosis of ultra high-risk gestational trophoblastic neoplasia patients: A retrospective cohort study. Gynecol Oncol 146, 81–86 (2017).

Horowitz NS, Goldstein DP & Berkowitz RS. Placental site trophoblastic tumors and epithelioid trophoblastic tumors: Biology, natural history, and treatment modalities. Gynecologic Oncology vol. 144 208–214 Preprint at https://doi.org/10.1016/j.ygyno.2016.10.024 (2017).

Powles T, et al. The significance of the time interval between antecedent pregnancy and diagnosis of high-risk gestational trophoblastic tumours patients and methods data collection. Br J Cancer 95, 1145–1147 (2006).

Gary Cunningham F, J. Leveno K, L. Bloom S, Y. Spong C, S. Dashe J, L.Hoffman B, et al. Williams Obstetrics. 25th ed. Cunningham FG, editor. McGraw-Hill Education; 2018. 593–603 p.

May, T., Goldstein, D. P. & Berkowitz, R. S. Current Chemotherapeutic Management of Patients with Gestational Trophoblastic Neoplasia. Chemotherapy Research and Practice 2011, 1–12 (2011).

Ghaemmaghami, F. & Ashraf-Ganjooie, T. Gestational trophoblastic neoplasia. Asia Pac J Clin Oncol 2, 9–21 (2006).

Friadi A. Update on the diagnosis of gestational trophoblastic disease.UMI Med J. 2019;4(2):20–30.

Jareemit, N., Horowitz, N. S., Goldstein, D. P., Berkowitz, R. S. & Elias, K. M. EMA vs EMACO in the treatment of gestational trophoblastic neoplasia. Gynecol Oncol 158, 99–104 (2020).




DOI: http://dx.doi.org/10.24198/obgynia.v6i3.493

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.


     
     

Creative Commons License
Indonesian Journal of Obstetrics & Gynecology Science is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License
  Web Analytics
  View My Stat